Changes in Central Venous Catheterization Bleeding Events After Implementing a Lower Trigger For Platelet Transfusion - an Observational Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Central venous catheters are essential when administering treatment for hematological conditions. Many patients have a decreased platelet count which increases the risk for bleeding complications. Baarle et al. recently published a randomized controlled study where withholding prophylactic platelet transfusions before CVC placement in patients with a platelet count of 10,000 to 50,000 per cubic millimeter did not meet the predefined margin for non-inferiority for postprocedural bleeding events (PMID: 37224197). However, bleedings grade 2 (defined as bleeding that requires external compression) were included despite lacking clinical significance. The aim of the present study is to investigate whether lowering the preprocedural platelet transfusion trigger from 50x10\^9/L to 10x10\^9/L for insertions of central venous catheters remains safe with regards to postprocedural bleeding events of grade 3-4.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• ≥ 18 years of age

• Indication for central venous catheter placement.

• Patients admitted to a hematological ward at the current department

Locations
Other Locations
Sweden
Thomas Kander
RECRUITING
Lund
Contact Information
Primary
Thomas Kander, PhD
thomas.kander@med.lu.se
+46 46 171163
Backup
Mathias Lazarevic Lindblad, MD
mathias.lazareviclindblad@skane.se
+46 46 175385
Time Frame
Start Date: 2024-02-26
Estimated Completion Date: 2026-04-20
Participants
Target number of participants: 500
Treatments
Before the change of the departmental pre-procedural platelet transfusion trigger for CVC placement
Patients ≥18 years of age admitted to a hematological ward at the current department, with an indication for CVC placement will be eligible for inclusion in the study
After the change of the departmental pre-procedural platelet transfusion trigger for CVC placement
Patients ≥18 years of age admitted to a hematological ward at the current department, with an indication for CVC placement will be eligible for inclusion in the study
Related Therapeutic Areas
Sponsors
Leads: Thomas Kander

This content was sourced from clinicaltrials.gov

Similar Clinical Trials